DOI: http://dx.doi.org/10.18203/issn.2454-5929.ijohns20202806

Pharmacotherapy for vertigo: a current perspective

Santosh Kumar Swain

Abstract


Vertigo is a symptom often encountered in routine clinical practice. Pharmacotherapy plays a vital role for treating the vertigo. Vestibular sedatives and drugs controlling nausea and vomiting constitute the important part of the pharmacotherapy for vertigo. Although there are several drugs available for controlling the vertigo, there are no definitive and universally accepted drugs available for treatment of vertigo. On the basis of the etiology, drugs with specific mechanism of action may be used to control this disabling symptom. Symptomatic treatment is often priority by many clinicians during the treatment of the vertigo. The pharmacological treatment of the vertigo is often decided after correct etiological evaluation of the symptom. Common drugs which are beneficial for treating vertigo are anticholinergics, antihistamines, benzodiazepines, calcium channel blockers and dopamine receptor antagonists. This review article exclusively focuses on pharmacotherapy of vertigo.


Keywords


Pharmacotherapy, Vertigo, Cinnarizine, Beta-histine, Dizziness

Full Text:

PDF

References


Young AS, Lechner C, Bradshaw AP, Dougall MHG, Black DA, Halmagyi GM, et al. Capturing acute vertigo: a vestibular event monitor. Neurology. 2019;92(24):2743-53.

Zwergal A, Strupp M, Brandt T. Advances in pharmacotherapy of vestibular and ocular motor disorders. Expert Opinion Pharmaco. 2019;20(10):1267-76.

Zatonski T, Temporale H, Holanowska J, Krecicki T. Current Views on Treatment of Vertigo and Dizziness. J Med Diagn Meth. 2014;2:150.

Swain SK, Baliarsingh D, Sahu MC. Vertigo among elderly people: Our experiences at a tertiary care teaching hospital of eastern India. Annals Indian Academy Otorhinolaryng Head Neck Surg. 2018;2(1):5.

Swain SK, Anand N, Mishra S. Vertigo among elderly people: current opinion. J Med Society. 2019;33(1):1.

Swain SK, Behera IC, Das A, Sahu MC. Prevalence of Benign Paroxysmal Positional Vertigo: our experiences at a tertiary care hospital of India. Egyptian J ENT Allied Sci. 2018;19(3):87-92.

Swain SK, Sahu MC, Samal R, Padhy RN. Incidence of hearing loss, tinnitus and vertigo among diabetes patients. Siriraj Med J. 2014;66:179-84.

Xue H, Chong Y, Jiang ZD, Liu ZL, Ding L, Yang SL, et al. Etiological analysis on patients with vertigo or dizziness. Zhonghua Yi Xue Za Zhi. 2018;98(16):1227-30.

Nerveen JV, Pompeiano O, Collewign H. Depression of the vestibule-ocular reflex and optokinetic responses in intra floccular microinjection of GABA-A and GABA-B agonists in rabbit. Arch Ital Biol. 1989;127:243-63.

Gilchrist D, Smith P, Darlington C. ACTH (4-10) accelerates ocular motor recovery in guinea pig’s medical vestibular neurons. Eur J Neurosci. 1995;7:555-62.

Daroff R. Dizziness, Vertigo. In Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL (Eds). Principles of Internal Medicine. New York, USA: McGraw Hill; 298; 144.

Takeda N, Mashahiro M, Hasegawa S, Kubo T, Matsunaga T. Neurochemical mechanisms of motion sickness. Am J Otolaryngol. 1989;10:351-9.

Bisht M, Bist SS. An update of pharmacotherapy of vertigo. J Chem Pharm Res. 2010;2(3):381-6.

Cohen B, Jong DJ. Meclizine and placebo in treating vertigo of vestibular origin, Relative efficacy a double-blind study. Arch Neurol. 1972;27:129-35.

Weinstein SE, Stern RM. Comparison of Marezine and Dramamine in preventing symptoms of motion sickness. Aviation Space Environmental Med. 1997;68:890-4.

Towse G. Cinnarizine a labyrinthine sedative. J Laryngol Otol. 1980;94(9):1009-15.

Berisavac II, Pavlovic AM, Trajkovic JJ, Sternic NM, Bumbasirevic LG. Drug treatment of vertigo in neurological disorders. Neurol India. 2015;63(6):933-9.

Scholtz AW, Steindl R, Burchardi N, Bognar-Steinberg I, Baumann W. Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with beta-histine in vestibular neuritis: a randomized, double-blind, non-inferiority study. Clin Drug Investig. 2012;32(6):387-99.

Gordon CR, Gonen A, Nachum Z, Doweck I, Spitzer O, Shupak A. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance. J Psychopharmacol. 2001;15(3):167-72.

Halmagyi GM. Vertigo and vestibular disorders In: Eadie J, (Ed). Drug therapy in neurology. Edinburgh: Churchill Livingston; 1992: 383.

Lacour M, Sterkers O. Histamine and beta-histine in the treatment of vertigo: Elucidation of mechanism of action. CNS Drugs. 2001;15:853-70.

Kameshwaran M, Sarda K. Therapeutic interventions in vertigo management. Int J Otorhinolaryngol Head Neck Surg. 2017;3(4):777-85.

Lacour M. Beta-histine treatment in managing vertigo and improving vestibular compensation: clarification. J Vestib Res. 2013;23(3):139-51.

Bisht M, Bist SS. An update on pharmacotherapy of vertigo. J Chem Pharm Res. 2010;2(3):381-6.

Singh AK, Chaturvedi VN. Prochlorperazine versus cinnarizine in cases of vertigo. Indian J Otolaryngol Head Neck Surg. 1998;50(4):392-7.

Biswas A. Vertigo-What is new in it from the general physician’s perspective. Med Update. 2012;22:586-91.

Rascol O, Hain TC, Brefel C, Benazet M, Clanet M, Montastruc JL. Antivertigo medications and drug induced vertigo. Drugs. 1995: 777-91.

Wilde MI, Markham A. Ondensetron: a review of its pharmacology and preliminary clinical findings in novel applications. Drugs. 1996;52:773-94.

Bosch D, Schmid S. Activation of muscarinic cholinergic receptors inhibits giant neurons in the caudal pontine reticular nucleus. Eur J Neurosci. 2006;24:1967-75.

Takeno K, Shimogori H, Takemoto T, Tanaka K, Mikuriya T, Orita H, et al. The systemic application of diazepam facilitates the reaquisition of a well-balanced vestibular function in a unilateral vestibular reinput model with intracochlear tetrodotoxin infusion using an osmotic pump. Brain Res. 2006;1096:113-9.

Hain TC, Uddin M. Pharmacological treatment of vertigo. CNS Drugs. 2003;17:85-100.

Prigioni I, Masetto S, Russo G, Taglietti V. Calcium current in solitary hair cells isolated from frog crista ampullaris. J Vestib Res. 1992;2(1):31-9.

Cohen B, Helwig D, Raphan T. Baclofen and velocity storage:a model of the effects of the drug on the vestibule-ocular reflex in the Rhesus monkey. J Physiol. 1987;393:703-26.

Pirodda A, Ferri GG, Raimondi MC, Borghi C. Diuretics in Meniere disease: a therapy or a potential cause of harm. Med Hypotheses. 2011;77(5):869-71.

Shea JJ. The role of dexamethasone or streptomycin perfusion TN the treatment of Meniere’s disease. Otolaryngologic Clin North Am. 1997;30:1051-9.

Strupp M, Dieterich M, Brandt T. The Treatment and Natural Course of Peripheral and Central Vertigo. Deutsches Arzteblatt Int. 2013;110 (29-30):505-16.

Casani AP, Piaggi P, Cerchiai N, Seccia V, Franceschini SS, Dallan I. Intra-tympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? a randomized controlled trial. Otolaryngol Head Neck Surg. 2012;146(3):430-7.

Cesarani A, Meloni F, Alpini D, Barozzi S, Verderio L, Boscani PF. Ginko biloba (EGb 761) in the treatment of equilibrium disorders. Adv Ther. 1998;15:291-304.

Swain SK, Behera IC, Sahu MC. Role of Ginko biloba for controlling residual dizziness after successful treatment of benign paroxysmal positional vertigo: our experiences at a tertiary care teaching hospital of Eastern India. Int J Health Allied Sci. 2018;7:196-200.

Oosterveld WJ. The effectiveness of piracetam in vertigo. Pharmacopsychiatry. 1999;32(1):54-60.

Freyss G, Vitte E. Strategie, diagnostic therapeutique devant un sujet de perte soudaine de la function vestibulaire. Cah Otolaryngol. 1990;15:569-82.

Dieterich M. Dizziness. Neurologist. 2004;10(3):154-64.